Blog

Victrex plc (LSE:VCT) has reported a softer start to its 2026 financial year, with first-quarter sales volumes down 4% and revenue declining 6% year on year. Growth in the Energy & Industrial segment was offset by weaker demand across transport, value-added resellers, and medical markets, although average selling prices remained broadly stable.

Management noted that volumes year to date to the end of January have now recovered to broadly match the prior year following a stronger January, but revenues remain slightly lower due to sales mix effects. The group reiterated its expectation that FY2026 will be a transitional year, weighted toward the second half, with first-half performance likely to fall short of last year’s levels.

Victrex ended the quarter with modest leverage, reporting net debt of £21.1m ahead of a significant dividend payment. The company continues to advance its Profit Improvement Plan, which focuses on simplifying the portfolio, improving operational efficiency, and reducing overheads. The programme is targeting at least £10m of annualised cost savings by FY2027, with the aim of strengthening competitiveness, lifting profitability, and supporting more sustainable medium- to long-term growth.

Overall, the company’s outlook reflects a stable balance sheet with strong equity backing and low leverage. Technical indicators point to some short-term bullish momentum, while valuation appears supportive given a relatively high dividend yield. These positives are tempered by ongoing challenges around revenue growth, profitability, and cautious sentiment following recent earnings commentary.

More about Victrex plc

Victrex plc is a UK-based specialist in high-performance polymer solutions, supplying advanced materials and increasingly semi-finished and finished components to markets including automotive, aerospace, energy and industrial, electronics, and medical. Its products are used in applications ranging from consumer electronics and vehicles to aircraft, energy systems, and medical devices, with the group positioning itself as an innovation-led supplier focused on performance, sustainability, and long-term value creation.

Jangada Mines plc (LSE:JAN) has reported encouraging exploration results from trenching, soil sampling, and drilling at its Paranaíta Gold Project in Brazil. Work at the TP-02 target has confirmed an 800-metre-long mineralised structure, with trench samples returning gold grades of up to 4.3 g/t. Additional soil sampling at the TP-3.2 area delivered strong results of up to 6.4 g/t, further highlighting the project’s potential.

The company has now completed around 1,100 metres of drilling, with initial assays from the first drill hole intersecting multiple mineralised zones grading up to 3.1 g/t over a combined 16.2 metres. Management said the results support its strategy to outline a shallow, open-pit mining operation and to significantly expand the existing JORC-compliant gold resource from 210,000 ounces toward a target of around 350,000 ounces, potentially increasing the project’s scale and value in the current gold price environment.

From a financial perspective, Jangada remains pre-revenue and continues to report losses and cash outflows, although it carries no debt. Technically, the shares show comparatively stronger signals, trading above key moving averages with moderately positive momentum. Valuation remains constrained by negative earnings and the absence of dividend support.

More about Jangada Mines plc

Jangada Mines plc is an AIM-quoted natural resources development company focused on Brazil, with gold as its primary commodity. The group’s core asset is the 7,211-hectare Paranaíta Gold Project, located in the Alta Floresta-Juruena Gold Province, where it is advancing open-pittable gold targets and working to expand compliant mineral resources under international reporting standards.

Finseta plc (LSE:FIN) has named Andrew Richards as interim Chief Financial Officer with immediate effect, following its recent update on the transition of its finance leadership. Richards has around 25 years’ experience across financial services and insurance, having held senior finance roles at life insurance consolidator Chesnara plc, alongside an earlier career at Deloitte.

Richards will work closely with outgoing CFO Judy Happe over the coming weeks to ensure a smooth handover, while the board continues its search for a permanent finance chief. The appointment is intended to provide continuity and reinforce financial oversight as Finseta continues to execute its growth strategy in international payments and multi-currency services.

Overall sentiment around the company reflects improving financial performance and a high degree of management confidence, supported by strategic initiatives and recent director share purchases. These positives are partly offset by bearish technical indicators and a valuation that appears moderate, suggesting a degree of caution in the near term.

More about Finseta plc

Finseta plc is a London-headquartered foreign exchange and payments group providing multi-currency accounts and payment solutions to both businesses and individuals. Using its proprietary technology platform combined with a high-touch service model, the company enables complex cross-border payments across more than 165 countries and 150 currencies. Finseta is regulated through its subsidiaries by the UK Financial Conduct Authority as an Electronic Money Institution, by Canada’s FINTRAC as a Money Services Business, and by the Dubai Financial Services Authority under a Category 3D licence.

Neo Energy Metals plc (LSE:NEO) has sought to reassure shareholders that its delayed Annual Financial Report for the year ended 30 September 2025 is close to completion. The company said publication is now expected in the week commencing 16 February 2026, following confirmation from its external auditors.

Trading in the company’s shares was temporarily suspended on the London Stock Exchange due to the short delay in finalising the accounts. Management expects the suspension to be lifted once the report is released, subject to standard exchange processes, and estimates the overall disruption to listing and trading will be limited to around two weeks. The company added that it is taking steps to strengthen internal controls to prevent similar delays in future, underlining a focus on improving governance and maintaining investor confidence.

More about Neo Energy Metals plc

Neo Energy Metals plc is a uranium development and mining company listed on the main market of the London Stock Exchange and South Africa’s A2X Markets. Through its South African subsidiaries, the group is assembling a sizeable uranium and gold portfolio, including 100% interests in the Beisa North and Beisa South Uranium and Gold Projects and the Beatrix 4 mine and processing complex in the Witwatersrand Basin. These assets together represent a SAMREC-compliant resource of 117 million pounds of U₃O₈ and more than 5 million ounces of gold. The company also holds up to a 70% interest in the advanced Henkries Uranium Project and a 100% stake in Henkries South, extending its uranium-bearing paleo-channel strike length to 46km in South Africa’s Northern Cape, and is led by a board with extensive experience in Southern African uranium and mineral development.

The Property Franchise Group PLC (LSE:TPFG) has responded positively to the Financial Conduct Authority’s interim review of the UK pure protection market, which concluded that product distribution is generally functioning effectively and delivering favourable outcomes for consumers. The regulator highlighted strong claims acceptance rates, low complaint levels, and indicated that no significant market-wide intervention is expected.

The group noted that the FCA’s comments on pricing practices and panel structures align closely with the approach already taken within its Financial Services division. TPFG also pointed to the regulator’s identification of a substantial “protection gap” and the added regulatory clarity provided by the report as reinforcing its confidence in the long-term opportunity to expand its involvement in helping customers access protection products.

From a performance perspective, the company continues to be supported by solid revenue growth and profitability, alongside constructive corporate developments and management confidence. While technical indicators suggest the potential for some short-term share price headwinds, valuation measures imply the stock is currently fairly priced.

More about The Property Franchise Group PLC

The Property Franchise Group PLC is the UK’s largest multi-brand property franchisor, operating a network of more than 1,946 outlets delivering residential property services, complemented by an established Financial Services arm. Founded in 1986, the AIM-listed group now owns 18 high-street and hybrid brands nationwide and participates in two major mortgage networks through its brokers Brook Financial (MAB) and The Mortgage Genie (Primis). Headquartered in Bournemouth, TPFG joined the AIM 100 index in July 2024.

Ondine Biomedical Inc. (LSE:OBI) has seen its Steriwave nasal photodisinfection technology recognised in the UK after a joint project with Mid Yorkshire Teaching NHS Trust won the Excellence in Healthcare Partnership Award. The local evaluation focused on orthopaedic surgery and reported a 71% reduction in surgical site infections in hip procedures, with no infections recorded in knee surgeries over the assessment period, alongside measurable cost savings.

The award win, together with the partnership’s shortlisting for the HSJ Partnership Awards, highlights increasing NHS interest in non-antibiotic approaches to infection prevention as concerns around antimicrobial resistance continue to grow. The results support broader deployment of Steriwave across English hospitals through Ondine’s distribution agreement with Mölnlycke Health Care, reinforcing its role as an alternative to traditional antibiotic-based protocols.

Despite the operational and clinical momentum, the company’s overall outlook remains challenged by financial pressures. Strong revenue growth has yet to translate into profitability or sustained positive cash flow, while technical indicators continue to point to negative share price momentum. Valuation metrics also remain unattractive, reflecting the early-stage and loss-making nature of the business.

More about Ondine Biomedical, Inc.

Ondine Biomedical Inc. is a Canadian life sciences company specialising in light-activated antimicrobial therapies, known as photodisinfection, for the prevention and treatment of infections, including those caused by multidrug-resistant organisms. Its proprietary Steriwave nasal photodisinfection system is approved in several international markets and is under clinical evaluation in the US, with a broader development pipeline targeting areas such as chronic sinusitis, ventilator-associated pneumonia, and burn-related infections.

Phoenix Spree Deutschland Limited (LSE:PSDL) reported a return to valuation growth across its Berlin residential portfolio in 2025, with like-for-like values per square metre rising 1.5% to €540.1m. The improvement reflects stabilisation within the Private Rented Sector portfolio, alongside stronger value gains from the company’s condominium assets.

The group’s condominium strategy delivered a record year, with 122 units notarised for €36m, exceeding its 2025 target by 20%. Sales were achieved at an average 3.9% premium to book value, with vacant units performing particularly strongly. All 40 homes in the existing condominium sales pool are now being marketed. Following the completion of a full debt refinancing in late 2025, Phoenix Spree plans to expand its condominium pipeline further in 2026 by adding 11 additional properties and widening its broker network to support transaction volumes.

Looking ahead, the company intends to return capital to shareholders through compulsory share redemptions, funded by ongoing asset disposals. This approach highlights a continued strategic shift away from long-term rental ownership toward portfolio realisation and cash returns. While recent free cash flow has been positive, the overall outlook remains constrained by several years of losses, uneven revenues, and a gradually weakening balance sheet. Share price technicals show a mild upward trend with neutral momentum, but valuation remains difficult to assess due to the absence of meaningful earnings and dividend metrics.

More about Phoenix Spree Deutschland Ltd

Phoenix Spree Deutschland Limited is a UK-listed investment company focused on residential real estate in Berlin. The group invests primarily in multifamily rental buildings and condominiums, seeking to create value through active asset management, targeted capital expenditure, and the selective conversion and sale of units as condominiums to benefit from strong owner-occupier demand in a supply-constrained market.

Derwent London plc (LSE:DLN) has agreed the disposal of its freehold asset at 80–85 Tottenham Court Road, W1, for £32.6 million, exceeding its June 2025 book value. The price equates to around £755 per square foot, with completion scheduled for June 2026.

The 43,300 sq ft mixed-use building includes 28,300 sq ft of office accommodation arranged over six floors, alongside four ground-floor retail units that together generate £1.7 million of annual income. The buyer is a newly formed value-add joint venture between Purestone Capital and BPS London. Chief executive Paul Williams commented that the transaction highlights continued investor demand for smaller value-add opportunities and demonstrates the group’s disciplined approach to capital recycling.

Sale proceeds are expected to be redeployed into higher-return opportunities, including major development schemes at Holden House in W1 and Greencoat & Gordon House in SW1. These investments align with Derwent London’s strategy of driving rental growth across prime central London locations. While the company’s share price technicals remain weak, its strong balance sheet, supportive valuation, and active portfolio management underpin a cautiously positive outlook.

More about Derwent London plc REIT

Derwent London plc is the largest London-focused office REIT, with a predominantly central London portfolio valued at £5.2 billion as of 30 June 2025. The group specialises in acquiring off-market assets in West End and City Borders locations and creating value through redevelopment, refurbishment, asset management, and capital recycling. Known for design-led regeneration projects such as 25 Baker Street and 1 Soho Place, Derwent London operates with modest leverage, targets net zero carbon status by 2030, and supports local communities through its long-established Central London Community Fund.

Tungsten West Plc (LSE:TUN) has raised approximately £41.37m in gross proceeds through an oversubscribed equity fundraising, combining a placing with institutional investors and a substantial direct subscription from a well-known international investor. The shares were issued at 18 pence each, a slight premium to the 30-day VWAP but still below the company’s most recent closing price.

The fundraising included £351,522 of participation from directors and significant backing from major shareholder Lansdowne. Proceeds are expected to strengthen the balance sheet, broaden the institutional shareholder base, and support progress toward securing project debt financing. Despite the successful raise, the company continues to face financial headwinds, including ongoing losses, cash outflows, and an expected move into negative equity in FY2025 as debt increases.

The new capital will be directed toward restarting and accelerating the recommissioning of the Hemerdon tungsten and tin mine in Devon, with management aiming to bring the asset back into production against a backdrop of strong tungsten and tin prices. Technical indicators point to a solid upward trend in the shares, although overbought conditions suggest some near-term risk. Valuation remains difficult to gauge given the lack of profitability and the absence of dividend support.

More about Tungsten West Plc

Tungsten West Plc is an AIM-listed mining company focused on restarting operations at the Hemerdon tungsten and tin mine in the UK. The company’s strategy is centered on bringing this strategically important asset back into production and positioning the business to benefit from demand for critical minerals.